Chemomab Therapeutics Ltd. Stock Split Ratio
Chemomab Therapeutics Ltd. (CMMB) reported Stock Split Ratio of 4.00% for the 0-month period ending 2021-03-16, per its 10-Q filed 2022-11-10.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2022-11-10
- 2021-03-16: Stockholders' Equity Note, Stock Split, Conversion Ratio 0 month 4.00%; Stockholders' Equity Note, Stock Split, Conversion Ratio 0 month as first filed 400.00%; Stockholders' Equity Note, Stock Split, Conversion Ratio 400.00%.
- 2018-06-30: Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month 1000.00%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio 0 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 0 month as first filed | Stockholders' Equity Note, Stock Split, Conversion Ratio | Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month |
|---|---|---|---|---|
| 2021-03-16 | 4.00% 10-Q · filed 2022-11-10 | 400.00% 10-Q · filed 2021-08-13 | 400.00% 10-Q · filed 2021-05-13 | |
| 2018-06-30 | 1000.00% 10-K · filed 2021-03-09 |